(Q34347446)

1 August 2017

1 reference

title

Problems related to resistance to cytarabine in acute myeloid leukemia (English)

1 reference

1 August 2017

1 reference

1 reference

Emeline Cros

1

1 reference

1 August 2017

Lars Jordheim

series ordinal

2

1 reference

1 August 2017

Charles Dumontet

series ordinal

3

1 reference

1 August 2017

Carlos M Galmarini

series ordinal

4

1 reference

1 August 2017

publication date

1 June 2004

1 reference

1 August 2017

1 reference

1 August 2017

volume

45

1 reference

1 August 2017

issue

6

1 reference

1 August 2017

page(s)

1123-1132

1 reference

P-glycoprotein, lung resistance-related protein and multidrug resistance associated protein in de novo acute non-lymphocytic leukaemias: biological and clinical implications.

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F1042819032000159861

Cytosine arabinoside transport and metabolism in acute leukemias and T cell lymphoblastic lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819032000159861

3'-Phosphorylated nucleotides are tight binding inhibitors of nucleoside diphosphate kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819032000159861

Lethality of human myeloblasts correlates with the incorporation of arabinofuranosylcytosine into DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819032000159861

Membrane transport influences the rate of accumulation of cytosine arabinoside in human leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819032000159861

Cytosine arabinoside influx and nucleoside transport sites in acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819032000159861

In vivo mechanisms of resistance to cytarabine in acute myeloid leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819032000159861

Expression of deoxycytidine kinase (dCK) gene in leukemic cells in childhood: decreased expression of dCK gene in relapsed leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819032000159861

Mechanisms of resistance of human acute leukaemia cells to cytosine arabinoside.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819032000159861

Deoxycytidine kinase and cN-II nucleotidase expression in blast cells predict survival in acute myeloid leukaemia patients treated with cytarabine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819032000159861

Role of IMP-selective 5'-nucleotidase (cN-II) in hematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819032000159861

Human cytosolic 5'-nucleotidase I: characterization and role in nucleoside analog resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819032000159861

The mechanism of adenosine formation in cells. Cloning of cytosolic 5'-nucleotidase-I

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819032000159861

Mammalian 5'(3')-deoxyribonucleotidase, cDNA cloning, and overexpression of the enzyme in Escherichia coli and mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819032000159861

Human erythrocyte pyrimidine 5'-nucleotidase, PN-I

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819032000159861

Expression of high Km 5'-nucleotidase in leukemic blasts is an independent prognostic factor in adults with acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819032000159861

Structural and functional analysis of the cytidine deaminase gene in patients with acute myeloid leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819032000159861

The molecular basis of mutations induced by deoxyribonucleoside triphosphate pool imbalances in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819032000159861

Treatment of normal and malignant cells with nucleoside analogues and etoposide enhances deoxycytidine kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819032000159861

Nucleoside analogues and nucleobases in cancer treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819032000159861

S-Acyl-2-thioethyl aryl phosphotriester derivatives as mononucleotide prodrugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819032000159861

Rational design of a new series of pronucleotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819032000159861

Fludarabine and cytosine arabinoside in the treatment of refractory or relapsed acute lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819032000159861

Pharmacokinetics of high-dose cytarabine and its deamination product--a reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819032000159861

Pyrimidine nucleotidases/phosphotransferases from human erythrocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819032000159861

The Effects of Cytosine Arabinoside on RNA-primed DNA Synthesis by DNA Polymerase α-Primase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819032000159861

Cytosine arabinoside lesions are position-specific topoisomerase II poisons and stimulate DNA cleavage mediated by the human type II enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819032000159861

Fludarabine potentiates metabolism of cytarabine in patients with acute myelogenous leukemia during therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819032000159861

Clinical Experience with Fludarabine in Leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819032000159861

10.1080/1042819032000159861

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference